With the addition of the J-Valve device, Vanderbilt Health now offers minimally invasive procedures to implant devices treating every valve disease. The trial is still enrolling new patients, so other high-risk patients with aortic regurgitation could qualify.

Using Fitbits, researchers set out to discover how many additional steps patients need to reduce risks of chronic disease.

Most of the 27 participants were able to reach altitudes of more than 18,000 feet — exclusively personal bests. All participants were under close medical supervision.

The program performed 149 lung transplants in 2025, the most ever in one year at Vanderbilt Health, and is now the second largest lung transplant center in the U.S.

A Chattanooga patient says she’s feeling great after becoming the first to receive the robotic‑assisted central line in Nashville.

Hospitals that earn accreditation have proven exceptional competency in treating patients with heart attack symptoms. The new designation will last until Jan. 31, 2029.